For example, recurrent deletions of the SETD2 locus were found in 3 % to 4 % of chronic lymphocytic leukemia (CLL) patients and these deletions are associated with loss of TP53, genomic complexity and chromothripsis. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.